Operating income increased 31.8%
Operating income changed +31.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +31.8% from the comparable as-filed period.
Operating margin changed +250 basis points from the comparable as-filed period.
Net income changed -19.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -58.4% from the comparable as-filed period.
SBC / revenue changed -200 basis points from the comparable as-filed period.
Revenue changed -4.0% from the comparable as-filed period.
Inventory changed -24.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +13.9% from the comparable as-filed period.
Inventory / revenue changed -129 basis points from the comparable as-filed period.
Research & development changed -8.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.